GENSIGHT BIOLOGICS

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy-based treatments of retinal degenerative diseases. Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from very low vision or blindness.

#SimilarOrganizations #People #Financial #Event #Website #More

GENSIGHT BIOLOGICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care Medical

Founded:

2012-01-01

Address:

Paris, Ile-de-France, France

Country:

France

Website Url:

http://www.gensight-biologics.com

Total Employee:

11+

Status:

Active

Contact:

+33 1 76 21 72 20

Email Addresses:

[email protected]

Total Funding:

188.93 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache Wordpress Plugins

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

entrada-therapeutics-logo

Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

kodiak-sciences-logo

Kodiak Sciences

Kodiak is designing and developing novel therapies for the treatment of retinal disease.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Advisors List

bernard-gilly_image

Bernard Gilly Chairman of the Board of Directors @ GenSight Biologics
Board_member

genghis-lloyd-harris_image

Genghis Lloyd-Harris Board of Directors @ GenSight Biologics
Board_member

botond-roska_image

Botond Roska Chairman @ GenSight Biologics
Board_member

Current Employees Featured

bernard-gilly_image

Bernard Gilly
Bernard Gilly CEO and Co-Founder @ GenSight Biologics
CEO and Co-Founder
2012-04-01

serge-picaud_image

Serge Picaud
Serge Picaud Founder @ GenSight Biologics
Founder

jose-alain-sahel_image

Jose Alain Sahel
Jose Alain Sahel Founder @ GenSight Biologics
Founder

luk-vandenberghe_image

Luk Vandenberghe
Luk Vandenberghe Co-Founder @ GenSight Biologics
Co-Founder
2011-11-01

thomas-gidoin_image

Thomas Gidoin
Thomas Gidoin CFO @ GenSight Biologics
CFO
2015-06-01

julio-benedicto_image

Julio Benedicto
Julio Benedicto Vice President, Marketing @ GenSight Biologics
Vice President, Marketing
2017-11-01

serge-fitoussi_image

Serge Fitoussi
Serge Fitoussi Director Clinical Operations Rare Diseases neuro-ophthalmology @ GenSight Biologics
Director Clinical Operations Rare Diseases neuro-ophthalmology
2013-11-01

jean-bennett_image

Jean Bennett
Jean Bennett Vice Chairman @ GenSight Biologics
Vice Chairman

isabelle-scarabin_image

Isabelle Scarabin
Isabelle Scarabin Director Business Development @ GenSight Biologics
Director Business Development
2013-09-01

sissel-rodahl_image

Sissel Rodahl
Sissel Rodahl SVP & Commercial Head @ GenSight Biologics
SVP & Commercial Head
2022-02-01

Founder

bernard-gilly_image

Bernard Gilly

botond-roska_image

Botond Roska

jose-alain-sahel_image

Jose Alain Sahel

luk-vandenberghe_image

Luk Vandenberghe

serge-picaud_image

Serge Picaud

Stock Details

Company's stock symbol is EPA:SIGHT

Investors List

invus_image

Key Employee Changes

Date	New article
2022-02-01	GenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe

Official Site Inspections

http://www.gensight-biologics.com Semrush global rank: 3.41 M Semrush visits lastest month: 4.59 K

Host Informations
Whois Informations

Loading ...